{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:09:40Z","timestamp":1789880980894,"version":"4.0.1"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s40478-016-0279-6","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T14:23:41Z","timestamp":1455027821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Animal modeling an oligodendrogliopathy \u2013 multiple system atrophy"],"prefix":"10.1186","volume":"4","author":[{"given":"Jonathan M.","family":"Bleasel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woojin Scott","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"key":"279_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.2006.103929","volume":"78","author":"S Papapetropoulos","year":"2007","unstructured":"Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, Mash DC. Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2007;78:327\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"279_CR2","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.21839","volume":"23","author":"A Schrag","year":"2008","unstructured":"Schrag A, Wenning GK, Quinn N, Ben\u2010Shlomo Y. Survival in multiple system atrophy. Mov Disord. 2008;23:294\u20136.","journal-title":"Mov Disord"},{"key":"279_CR3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00401-007-0254-1","volume":"114","author":"T Ozawa","year":"2007","unstructured":"Ozawa T. Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum. Acta Neuropathol. 2007;114:201\u201311.","journal-title":"Acta Neuropathol"},{"key":"279_CR4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/mds.870120203","volume":"12","author":"G Wenning","year":"1997","unstructured":"Wenning G, Tison F, Ben Shlomo Y, Daniel S, Quinn N. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133\u201347.","journal-title":"Mov Disord"},{"key":"279_CR5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015;372:1375\u20136. doi: 10.1056\/NEJMc1501657 .","journal-title":"N Engl J Med"},{"key":"279_CR6","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","volume":"127","author":"T Ozawa","year":"2004","unstructured":"Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain. 2004;127:2657\u201371.","journal-title":"Brain"},{"key":"279_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000078506","volume":"23","author":"V Chrysostome","year":"2004","unstructured":"Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology. 2004;23:201\u20138.","journal-title":"Neuroepidemiology"},{"key":"279_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01826052","volume":"1","author":"LE Nee","year":"1991","unstructured":"Nee LE, Gomez MR, Dambrosia J, Bale S, Eldridge R, Polinsky RJ. Environmental\u2014occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation. Clin Auton Res. 1991;1:9\u201313.","journal-title":"Clin Auton Res"},{"key":"279_CR9","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/mds.23185","volume":"25","author":"JH Seo","year":"2010","unstructured":"Seo JH, Yong SW, Song SK, Lee JE, Sohn YH, Lee PH. A case\u2013control study of multiple system atrophy in Korean patients. Mov Disord. 2010;25:1953\u20139.","journal-title":"Mov Disord"},{"key":"279_CR10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.20303","volume":"20","author":"N Vanacore","year":"2005","unstructured":"Vanacore N, Bonifati V, Fabbrini G, Colosimo C, De Michele G, Marconi R, et al. Case\u2013control study of multiple system atrophy. Mov Disord. 2005;20:158\u201363.","journal-title":"Mov Disord"},{"key":"279_CR11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/mds.21857","volume":"23","author":"JS Vidal","year":"2008","unstructured":"Vidal JS, Vidailhet M, Elbaz A, Derkinderen P, Tzourio C, Alperovitch A. Risk factors of multiple system atrophy: a case\u2013control study in French patients. Mov Disord. 2008;23:797\u2013803.","journal-title":"Mov Disord"},{"key":"279_CR12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/ana.21889","volume":"67","author":"JY Yun","year":"2009","unstructured":"Yun JY, Lee WW, Lee JY, Kim HJ, Park SS, Jeon BS. SNCA variants and multiple system atrophy. Ann Neurol. 2009;67:554\u20135.","journal-title":"Ann Neurol"},{"key":"279_CR13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archneur.64.4.545","volume":"64","author":"K Hara","year":"2007","unstructured":"Hara K, Momose Y, Tokiguchi S, Shimohata M, Terajima K, Onodera O, et al. Multiplex families with multiple system atrophy. Arch Neurol. 2007;64:545\u201351.","journal-title":"Arch Neurol"},{"key":"279_CR14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2005.09.003","volume":"240","author":"H Soma","year":"2006","unstructured":"Soma H, Yabe I, Takei A, Fujiki N, Yanagihara T, Sasaki H. Heredity in multiple system atrophy. J Neurol Sci. 2006;240:107\u201310.","journal-title":"J Neurol Sci"},{"key":"279_CR15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/jnnp.2008.158949","volume":"80","author":"U W\u00fcllner","year":"2009","unstructured":"W\u00fcllner U, Schmitt I, Kammal M, Kretzschmar HA, Neumann M. Definite multiple system atrophy in a German family. J Neurol Neurosurg Psychiatry. 2009;80:449\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"279_CR16","doi-asserted-by":"crossref","first-page":"e7114","DOI":"10.1371\/journal.pone.0007114","volume":"4","author":"A Al-Chalabi","year":"2009","unstructured":"Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, et al. Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS One. 2009;4:e7114.","journal-title":"PLoS One"},{"key":"279_CR17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ana.21786","volume":"67","author":"OA Ross","year":"2010","unstructured":"Ross OA, Vilari\u00f1o\u2010G\u00fcell C, Wszolek ZK, Farrer MJ, Dickson DW. Reply to: SNCA variants are associated with increased risk of multiple system atrophy. Ann Neurol. 2010;67:414\u20135.","journal-title":"Ann Neurol"},{"key":"279_CR18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/ana.21685","volume":"65","author":"SW Scholz","year":"2009","unstructured":"Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, et al. SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol. 2009;65:610\u20134.","journal-title":"Ann Neurol"},{"key":"279_CR19","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1002\/mds.24069","volume":"27","author":"A Sailer","year":"2012","unstructured":"Sailer A, On behalf of the MSA GWAS Consortium. First genome-wide association study in multiple system atrophy (abstract). Mov Disord. 2012;27:S585.","journal-title":"Mov Disord"},{"key":"279_CR20","doi-asserted-by":"crossref","unstructured":"1 (2013) Mutations in COQ2 in familial and sporadic multiple-system atrophy. The New England journal of medicine 369: 233\u2013244 doi: 10.1056\/NEJMoa1212115","DOI":"10.1056\/NEJMoa1212115"},{"key":"279_CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/acn3.185","volume":"2","author":"J Mitsui","year":"2015","unstructured":"Mitsui J, Matsukawa T, Sasaki H, Yabe I, Matsushima M, Durr A, et al. Variants associated with Gaucher disease in multiple system atrophy. Ann Clin Transl Neurol. 2015;2:417\u201326. doi: 10.1002\/acn3.185 .","journal-title":"Ann Clin Transl Neurol"},{"key":"279_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-014-0430-0","volume":"16","author":"JD Mills","year":"2015","unstructured":"Mills JD, Kim WS, Halliday GM, Janitz M. Transcriptome analysis of grey and white matter cortical tissue in multiple system atrophy. Neurogenetics. 2015;16:107\u201322. doi: 10.1007\/s10048-014-0430-0 .","journal-title":"Neurogenetics"},{"key":"279_CR23","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ejn.12444","volume":"39","author":"K Ubhi","year":"2014","unstructured":"Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, et al. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. Eur J Neurosci. 2014;39:1026\u201341. doi: 10.1111\/ejn.12444 .","journal-title":"Eur J Neurosci"},{"key":"279_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2051-5960-2-15","volume":"2","author":"JM Bleasel","year":"2014","unstructured":"Bleasel JM, Wong JH, Halliday GM, Kim WS. Lipid dysfunction and pathogenesis of multiple system atrophy. Acta neuropathologica communications. 2014;2:15. doi: 10.1186\/2051-5960-2-15 .","journal-title":"Acta neuropathologica communications"},{"key":"279_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s40478-014-0150-6","volume":"2","author":"AS Don","year":"2014","unstructured":"Don AS, Hsiao JH, Bleasel JM, Couttas TA, Halliday GM, Kim WS. Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy. Acta neuropathologica communications. 2014;2:150. doi: 10.1186\/s40478-014-0150-6 .","journal-title":"Acta neuropathologica communications"},{"key":"279_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40478-015-0208-0","volume":"3","author":"K Nakamura","year":"2015","unstructured":"Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, et al. Filamentous aggregations of phosphorylated alpha-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy. Acta Neuropathol Commun. 2015;3:29. doi: 10.1186\/s40478-015-0208-0 .","journal-title":"Acta Neuropathol Commun"},{"key":"279_CR27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","volume":"94","author":"MI Papp","year":"1989","unstructured":"Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989;94:79\u2013100.","journal-title":"J Neurol Sci"},{"key":"279_CR28","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1046\/j.1471-4159.1999.02093.x","volume":"73","author":"W Gai","year":"1999","unstructured":"Gai W, Power J, Blumbergs P, Culvenor J, Jensen P. Alpha-synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J Neurochem. 1999;73:2093\u2013100.","journal-title":"J Neurochem"},{"key":"279_CR29","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1021\/bi991447r","volume":"39","author":"KA Conway","year":"2000","unstructured":"Conway KA, Harper JD, Lansbury Jr PT. Fibrils formed in vitro from \u03b1-synuclein and two mutant forms linked to Parkinson\u2019s disease are typical amyloid. Biochemistry. 2000;39:2552\u201363.","journal-title":"Biochemistry"},{"key":"279_CR30","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","volume":"97","author":"LC Serpell","year":"2000","unstructured":"Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA. Fiber diffraction of synthetic \u03b1-synuclein filaments shows amyloid-like cross-\u03b2 conformation. Proc Natl Acad Sci U S A. 2000;97:4897\u2013902.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"279_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb841","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4:160\u20134.","journal-title":"Nat Cell Biol"},{"key":"279_CR32","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","volume":"277","author":"M Hasegawa","year":"2002","unstructured":"Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM-Y, et al. Phosphorylated \u03b1-synuclein is ubiquitinated in \u03b1-synucleinopathy lesions. J Biol Chem. 2002;277:49071\u20136.","journal-title":"J Biol Chem"},{"key":"279_CR33","doi-asserted-by":"crossref","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson WS, Jonas A, Clayton DF, George JM. Stabilization of \u03b1-synuclein secondary structure upon binding to synthetic membranes. J Biol Chem. 1998;273:9443\u20139.","journal-title":"J Biol Chem"},{"key":"279_CR34","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1523\/JNEUROSCI.1594-04.2004","volume":"24","author":"DL Fortin","year":"2004","unstructured":"Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, Edwards RH. Lipid rafts mediate the synaptic localization of \u03b1-synuclein. J Neurosci. 2004;24:6715\u201323.","journal-title":"J Neurosci"},{"key":"279_CR35","doi-asserted-by":"crossref","first-page":"19666","DOI":"10.1073\/pnas.0807826105","volume":"105","author":"CC Jao","year":"2008","unstructured":"Jao CC, Hegde BG, Chen J, Haworth IS, Langen R. Structure of membrane-bound \u03b1-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A. 2008;105:19666\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"279_CR36","doi-asserted-by":"crossref","first-page":"34328","DOI":"10.1074\/jbc.M004345200","volume":"275","author":"E Jo","year":"2000","unstructured":"Jo E, McLaurin J, Yip CM, St George-Hyslop P, Fraser PE. alpha-Synuclein membrane interactions and lipid specificity. J Biol Chem. 2000;275:34328\u201334.","journal-title":"J Biol Chem"},{"key":"279_CR37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/brain\/awp282","volume":"133","author":"J Tong","year":"2010","unstructured":"Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, et al. Brain \u03b1-synuclein accumulation in multiple system atrophy, Parkinson\u2019s disease and progressive supranuclear palsy: a comparative investigation. Brain. 2010;133:172\u201388.","journal-title":"Brain"},{"key":"279_CR38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","volume":"76","author":"BC Campbell","year":"2001","unstructured":"Campbell BC, McLean CA, Culvenor JG, Gai WP, Blumbergs PC, Jakala P, et al. The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson\u2019s disease. J Neurochem. 2001;76:87\u201396.","journal-title":"J Neurochem"},{"key":"279_CR39","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","volume":"155","author":"D Dickson","year":"1999","unstructured":"Dickson D, Liu WK, Hardy J, Farrer M, Mehta N, Uitti R, et al. Widespread alterations of \u03b1-synuclein in multiple system atrophy. Am J Pathol. 1999;155:1241\u201351.","journal-title":"Am J Pathol"},{"key":"279_CR40","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jnen\/59.9.830","volume":"59","author":"JE Duda","year":"2000","unstructured":"Duda JE, Giasson BI, Gur TL, Montine TJ, Robertson D, Biaggioni I, et al. Immunohistochemical and biochemical studies demonstrate a distinct profile of [alpha]-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol. 2000;59:830.","journal-title":"J Neuropathol Exp Neurol"},{"key":"279_CR41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","volume":"3","author":"PJ Kahle","year":"2002","unstructured":"Kahle PJ, Neumann M, Ozmen L, M\u00fcller V, Jacobsen H, Spooren W, et al. Hyperphosphorylation and insolubility of \u03b1-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 2002;3:583\u20138.","journal-title":"EMBO Rep"},{"key":"279_CR42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03159976","volume":"16","author":"GR Post","year":"1992","unstructured":"Post GR, Dawson G. Characterization of a cell line derived from a human oligodendroglioma. Mol Chem Neuropathol. 1992;16:303\u201317.","journal-title":"Mol Chem Neuropathol"},{"key":"279_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00684804","volume":"46","author":"E Miyake","year":"1979","unstructured":"Miyake E. Establishment of a human oligodendroglial cell line. Acta Neuropathol. 1979;46:51\u20135.","journal-title":"Acta Neuropathol"},{"key":"279_CR44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/neu.480260212","volume":"26","author":"J McLaurin","year":"1995","unstructured":"McLaurin J, Trudel GC, Shaw IT, Antel JP, Cashman NR. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol. 1995;26:283\u201393.","journal-title":"J Neurobiol"},{"key":"279_CR45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8","volume":"45","author":"C Richter\u2010Landsberg","year":"1996","unstructured":"Richter\u2010Landsberg C, Heinrich M. OLN\u201093: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res. 1996;45:161\u201373.","journal-title":"J Neurosci Res"},{"key":"279_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1027324230923","volume":"32","author":"M Buntinx","year":"2003","unstructured":"Buntinx M, Vanderlocht J, Hellings N, Vandenabeele F, Lambrichts I, Raus J, et al. Characterization of three human oligodendroglial cell lines as a model to study oligodendrocyte injury: morphology and oligodendrocyte-specific gene expression. J Neurocytol. 2003;32:25\u201338.","journal-title":"J Neurocytol"},{"key":"279_CR47","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20540","volume":"20","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Poewe W, Wenning GK. In vitro models of multiple system atrophy. Mov Disord. 2005;20:S53\u201356.","journal-title":"Mov Disord"},{"key":"279_CR48","doi-asserted-by":"crossref","first-page":"10211","DOI":"10.1074\/jbc.M809671200","volume":"284","author":"CL Kragh","year":"2009","unstructured":"Kragh CL, Lund LB, Febbraro F, Hansen HD, Wei-Ping G, El-Agnaf O, et al. alpha-synuclein aggregation and Ser-129 phosphorylation-dependent cell death in oligodendroglial cells. J Biol Chem. 2009;284:10211\u201322.","journal-title":"J Biol Chem"},{"key":"279_CR49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2353\/ajpath.2009.080503","volume":"174","author":"K Nakayama","year":"2009","unstructured":"Nakayama K, Suzuki Y, Yazawa I. Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy. Am J Pathol. 2009;174:1471\u201380.","journal-title":"Am J Pathol"},{"key":"279_CR50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0306-4522(00)00171-8","volume":"99","author":"C Scherfler","year":"2000","unstructured":"Scherfler C, Puschban Z, Ghorayeb I, Goebel G, Tison F, Jellinger K, et al. Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy). Neuroscience. 2000;99:43\u201354.","journal-title":"Neuroscience"},{"key":"279_CR51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/exnr.2000.7535","volume":"167","author":"I Ghorayeb","year":"2001","unstructured":"Ghorayeb I, Puschban Z, Fernagut PO, Scherfler C, Rouland R, Wenning GK, et al. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. Exp Neurol. 2001;167:133\u201347.","journal-title":"Exp Neurol"},{"key":"279_CR52","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0306-4522(00)00500-5","volume":"102","author":"R Waldner","year":"2001","unstructured":"Waldner R, Puschban Z, Scherfler C, Seppi K, Jellinger K, Poewe W, et al. No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). Neuroscience. 2001;102:581\u201392.","journal-title":"Neuroscience"},{"key":"279_CR53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mds.870110507","volume":"11","author":"G Wenning","year":"1996","unstructured":"Wenning G, Granata R, Laboyrie P, Quinn N, Jenner P, Marsden C. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Disord. 1996;11:522\u201332.","journal-title":"Mov Disord"},{"key":"279_CR54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/syn.21719","volume":"68","author":"PO Fernagut","year":"2014","unstructured":"Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, et al. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Synapse. 2014;68:98\u2013106.","journal-title":"Synapse"},{"key":"279_CR55","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0002-9440(10)62307-3","volume":"166","author":"N Stefanova","year":"2005","unstructured":"Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, et al. Oxidative stress in transgenic mice with oligodendroglial \u03b1-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol. 2005;166:869\u201376.","journal-title":"Am J Pathol"},{"key":"279_CR56","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.expneurol.2010.05.008","volume":"224","author":"S Stemberger","year":"2010","unstructured":"Stemberger S, Poewe W, Wenning GK, Stefanova N. Targeted overexpression of human \u03b1-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol. 2010;224:459\u201364.","journal-title":"Exp Neurol"},{"key":"279_CR57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.expneurol.2013.02.002","volume":"247","author":"D Kuzdas","year":"2013","unstructured":"Kuzdas D, Stemberger S, Gaburro S, Stefanova N, Singewald N, Wenning GK. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Exp Neurol. 2013;247:531\u20136.","journal-title":"Exp Neurol"},{"key":"279_CR58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/mds.25336","volume":"28","author":"M Boudes","year":"2013","unstructured":"Boudes M, Uvin P, Pinto S, Voets T, Fowler CJ, Wenning GK, et al. Bladder dysfunction in a transgenic mouse model of multiple system atrophy. Mov Disord. 2013;28:347\u201355.","journal-title":"Mov Disord"},{"key":"279_CR59","doi-asserted-by":"crossref","first-page":"10689","DOI":"10.1523\/JNEUROSCI.3527-05.2005","volume":"25","author":"CW Shults","year":"2005","unstructured":"Shults CW, Rockenstein E, Crews L, Adame A, Mante M, Larrea G, et al. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. J Neurosci. 2005;25:10689\u201399.","journal-title":"J Neurosci"},{"key":"279_CR60","doi-asserted-by":"crossref","first-page":"e64625","DOI":"10.1371\/journal.pone.0064625","volume":"8","author":"F Krismer","year":"2013","unstructured":"Krismer F, Wenning GK, Li Y, Poewe W, Stefanova N. Intact olfaction in a mouse model of multiple system atrophy. PLoS One [Electronic Resource]. 2013;8:e64625.","journal-title":"PLoS One [Electronic Resource]"},{"key":"279_CR61","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2377-11-157","volume":"11","author":"M Suzuki","year":"2011","unstructured":"Suzuki M, Hashimoto M, Yoshioka M, Murakami M, Kawasaki K, Urashima M. The odor stick identification test for Japanese differentiates Parkinson\u2019s disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol. 2011;11:157.","journal-title":"BMC Neurol"},{"key":"279_CR62","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neuron.2005.01.032","volume":"45","author":"I Yazawa","year":"2005","unstructured":"Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, et al. Mouse model of multiple system atrophy \u03b1-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron. 2005;45:847\u201359.","journal-title":"Neuron"},{"key":"279_CR63","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2990.2004.00564.x","volume":"30","author":"M Nishie","year":"2004","unstructured":"Nishie M, Mori F, Yoshimoto M, Takahashi H, Wakabayashi K. A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy. Neuropathol Appl Neurobiol. 2004;30:546\u201354.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"279_CR64","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1093\/brain\/awv114","volume":"138","author":"MD Cykowski","year":"2015","unstructured":"Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, et al. Expanding the spectrum of neuronal pathology in multiple system atrophy. Brain. 2015;138:2293\u2013309. doi: 10.1093\/brain\/awv114 .","journal-title":"Brain"},{"issue":"Pt 2","key":"279_CR65","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","volume":"117","author":"MI Papp","year":"1994","unstructured":"Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain. 1994;117(Pt 2):235\u201343.","journal-title":"Brain"},{"key":"279_CR66","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/brain\/awv151","volume":"138","author":"GM Halliday","year":"2015","unstructured":"Halliday GM. Re-evaluating the glio-centric view of multiple system atrophy by highlighting the neuronal involvement. Brain. 2015;138:2116\u20139. doi: 10.1093\/brain\/awv151 .","journal-title":"Brain"},{"key":"279_CR67","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1460-9568.2007.05757.x","volume":"26","author":"AM Jeannotte","year":"2007","unstructured":"Jeannotte AM, Sidhu A. Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. Eur J Neurosci. 2007;26:1509\u201320.","journal-title":"Eur J Neurosci"},{"key":"279_CR68","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1111\/j.1460-9568.2006.05210.x","volume":"24","author":"HJ Lee","year":"2006","unstructured":"Lee HJ, Khoshaghideh F, Lee S, Lee SJ. Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Eur J Neurosci. 2006;24:3153\u201362.","journal-title":"Eur J Neurosci"},{"key":"279_CR69","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2007.11.020","volume":"365","author":"M Kim","year":"2008","unstructured":"Kim M, Jung W, Lee I-H, Bhak G, Paik SR, Hahn J-S. Impairment of microtubule system increases \u03b1-synuclein aggregation and toxicity. Biochem Biophys Res Commun. 2008;365:628\u201335.","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR70","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1074\/jbc.M410409200","volume":"280","author":"E Lindersson","year":"2005","unstructured":"Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, et al. p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem. 2005;280:5703\u201315. doi: 10.1074\/jbc.M410409200 .","journal-title":"J Biol Chem"},{"key":"279_CR71","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science. 2003;300:636\u201340.","journal-title":"Science"},{"key":"279_CR72","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/glia.20909","volume":"58","author":"A Lehotzky","year":"2010","unstructured":"Lehotzky A, Lau P, T\u0151k\u00e9si N, Muja N, Hudson LD, Ov\u00e1di J. Tubulin polymerization\u2010promoting protein (TPPP\/p25) is critical for oligodendrocyte differentiation. Glia. 2010;58:157\u201368.","journal-title":"Glia"},{"key":"279_CR73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/15216540500381101","volume":"57","author":"J Ovadi","year":"2005","unstructured":"Ovadi J, Orosz F, Lebotzky A. What is the biological significance of the brain\u2010specific tubulin\u2010polymerization promoting protein (TPPP\/p25)? IUBMB Life. 2005;57:765\u20138.","journal-title":"IUBMB Life"},{"key":"279_CR74","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2353\/ajpath.2007.070201","volume":"171","author":"YJ Song","year":"2007","unstructured":"Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, et al. p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol. 2007;171:1291\u2013303. doi: 10.2353\/ajpath.2007.070201 .","journal-title":"Am J Pathol"},{"key":"279_CR75","first-page":"136","volume":"2","author":"K Ota","year":"2014","unstructured":"Ota K, Obayashi M, Ozaki K, Ichinose S, Kakita A, Tada M, et al. Relocation of p25alpha\/tubulin polymerization promoting protein from the nucleus to the perinuclear cytoplasm in the oligodendroglia of sporadic and COQ2 mutant multiple system atrophy. Acta Neuropathol Commun. 2014;2:136. doi: 10.1186\/s40478-014-0136-4 .","journal-title":"Acta Neuropathol Commun"},{"key":"279_CR76","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.bbrc.2011.12.092","volume":"417","author":"K Nakayama","year":"2012","unstructured":"Nakayama K, Suzuki Y, Yazawa I. Binding of neuronal alpha-synuclein to beta-III tubulin and accumulation in a model of multiple system atrophy. Biochem Biophys Res Commun. 2012;417:1170\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2012.10.057","volume":"428","author":"H Ito","year":"2012","unstructured":"Ito H, Nakayama K, Jin C, Suzuki Y, Yazawa I. alpha-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy. Biochem Biophys Res Commun. 2012;428:348\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0306-4522(02)00205-1","volume":"114","author":"P Fernagut","year":"2002","unstructured":"Fernagut P, Diguet E, Stefanova N, Biran M, Wenning G, Canioni P, et al. Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl\/6 mice: behavioural and histopathological characterisation. Neuroscience. 2002;114:1005\u201317.","journal-title":"Neuroscience"},{"key":"279_CR79","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1002\/jnr.22089","volume":"87","author":"K Ubhi","year":"2009","unstructured":"Ubhi K, Lee PH, Adame A, Inglis C, Mante M, Rockenstein E, et al. Mitochondrial inhibitor 3\u2010nitroproprionic acid enhances oxidative modification of alpha\u2010synuclein in a transgenic mouse model of multiple system atrophy. J Neurosci Res. 2009;87:2728\u201339.","journal-title":"J Neurosci Res"},{"key":"279_CR80","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/pmic.200700679","volume":"8","author":"M Zouambia","year":"2008","unstructured":"Zouambia M, Fischer DF, Hobo B, De Vos RA, Hol EM, Varndell IM, et al. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses. Proteomics. 2008;8:1221\u201336.","journal-title":"Proteomics"},{"key":"279_CR81","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00702-008-0027-6","volume":"115","author":"N MacInnes","year":"2008","unstructured":"MacInnes N, Iravani MM, Perry E, Piggott M, Perry R, Jenner P, et al. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems. J Neural Transm. 2008;115:869\u201378.","journal-title":"J Neural Transm"},{"key":"279_CR82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"P St","year":"2003","unstructured":"St P, McNaught K, Belizaire R, Isacson O, Jenner P, Olanow CW. Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol. 2003;179:38\u201346.","journal-title":"Exp Neurol"},{"key":"279_CR83","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainres.2010.02.045","volume":"1326","author":"S Bukhatwa","year":"2010","unstructured":"Bukhatwa S, Zeng B-Y, Rose S, Jenner P. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson\u2019s disease, multiple system atrophy and progressive supranuclear palsy. Brain Res. 2010;1326:174\u201383.","journal-title":"Brain Res"},{"key":"279_CR84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-012-0977-5","volume":"124","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Kaufmann WA, Humpel C, Poewe W, Wenning GK. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy. Acta Neuropathol. 2012;124:51\u201365. doi: 10.1007\/s00401-012-0977-5 .","journal-title":"Acta Neuropathol"},{"issue":"31\u201332","key":"279_CR85","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12031-009-9190-y","volume":"39","author":"M Riedel","year":"2009","unstructured":"Riedel M, Goldbaum O, Richter-Landsberg C. alpha-Synuclein promotes the recruitment of tau to protein inclusions in oligodendroglial cells: Effects of oxidative and proteolytic stress. J Mol Neurosci. 2009;39(31\u201332):226\u201334.","journal-title":"J Mol Neurosci"},{"key":"279_CR86","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jnr.10245","volume":"68","author":"Y Du","year":"2002","unstructured":"Du Y, Dreyfus CF. Oligodendrocytes as providers of growth factors. J Neurosci Res. 2002;68:647\u201354.","journal-title":"J Neurosci Res"},{"key":"279_CR87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tins.2011.08.003","volume":"34","author":"K Ubhi","year":"2011","unstructured":"Ubhi K, Low P, Masliah E. Multiple system atrophy: a clinical and neuropathological perspective. [Review]. Trends Neurosci. 2011;34:581\u201390.","journal-title":"Trends Neurosci"},{"key":"279_CR88","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1523\/JNEUROSCI.23-12-04967.2003","volume":"23","author":"A Wilkins","year":"2003","unstructured":"Wilkins A, Majed H, Layfield R, Compston A, Chandran S. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci. 2003;23:4967\u201374.","journal-title":"J Neurosci"},{"key":"279_CR89","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1523\/JNEUROSCI.0567-10.2010","volume":"30","author":"K Ubhi","year":"2010","unstructured":"Ubhi K, Rockenstein E, Mante M, Inglis C, Adame A, Patrick C, et al. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors. J Neurosci. 2010;30:6236\u201346.","journal-title":"J Neurosci"},{"key":"279_CR90","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","volume":"113","author":"A Jang","year":"2010","unstructured":"Jang A, Lee HJ, Suk JE, Jung JW, Kim KP, Lee SJ. Non\u2010classical exocytosis of \u03b1\u2010synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem. 2010;113:1263\u201374.","journal-title":"J Neurochem"},{"key":"279_CR91","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","volume":"25","author":"HJ Lee","year":"2005","unstructured":"Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of \u03b1-synuclein and its aggregates. J Neurosci. 2005;25:6016\u201324.","journal-title":"J Neurosci"},{"key":"279_CR92","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","volume":"17","author":"OM El-Agnaf","year":"2003","unstructured":"El-Agnaf OM, Salem SA, Paleologou KE, Cooper LJ, Fullwood NJ, Gibson MJ, et al. \u03b1-Synuclein implicated in Parkinson\u2019s disease is present in extracellular biological fluids, including human plasma. FASEB J. 2003;17:1945\u20137.","journal-title":"FASEB J"},{"key":"279_CR93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2006.08.024","volume":"349","author":"T Tokuda","year":"2006","unstructured":"Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, Qureshi MM, et al. Decreased \u03b1-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson\u2019s disease. Biochem Biophys Res Commun. 2006;349:162\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR94","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","volume":"106","author":"P Desplats","year":"2009","unstructured":"Desplats P, Lee H-J, Bae E-J, Patrick C, Rockenstein E, Crews L, et al. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of \u03b1-synuclein. Proc Natl Acad Sci. 2009;106:13010\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"279_CR95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","volume":"372","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Suk JE, Bae EJ, Lee SJ. Clearance and deposition of extracellular \u03b1-synuclein aggregates in microglia. Biochem Biophys Res Commun. 2008;372:423\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"279_CR96","doi-asserted-by":"crossref","first-page":"27441","DOI":"10.1074\/jbc.M101318200","volume":"276","author":"JY Sung","year":"2001","unstructured":"Sung JY, Kim J, Paik SR, Park JH, Ahn YS, Chung KC. Induction of neuronal cell death by Rab5A-dependent endocytosis of \u03b1-synuclein. J Biol Chem. 2001;276:27441\u20138.","journal-title":"J Biol Chem"},{"key":"279_CR97","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body\u2013like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med. 2008;14:504\u20136.","journal-title":"Nat Med"},{"key":"279_CR98","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"J-Y Li","year":"2008","unstructured":"Li J-Y, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501\u20133.","journal-title":"Nat Med"},{"key":"279_CR99","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C, Bae E-J, Cho J-H, Rho S, et al. Direct transfer of \u03b1-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem. 2010;285:9262\u201372.","journal-title":"J Biol Chem"},{"key":"279_CR100","doi-asserted-by":"crossref","first-page":"e46817","DOI":"10.1371\/journal.pone.0046817","volume":"7","author":"H Kisos","year":"2012","unstructured":"Kisos H, Pukas K, Ben-Hur T, Richter-Landsberg C, Sharon R. Increased neuronal alpha-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling alpha-synucleinopathies. PLoS One [Electronic Resource]. 2012;7:e46817.","journal-title":"PLoS One [Electronic Resource]"},{"key":"279_CR101","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-7-38","volume":"7","author":"M Konno","year":"2012","unstructured":"Konno M, Hasegawa T, Baba T, Miura E, Sugeno N, Kikuchi A, et al. Suppression of dynamin GTPase decreases alpha-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener. 2012;7:38.","journal-title":"Mol Neurodegener"},{"key":"279_CR102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/glia.22611","volume":"62","author":"JF Reyes","year":"2014","unstructured":"Reyes JF, Rey NL, Bousset L, Melki R, Brundin P, Angot E. Alpha\u2010synuclein transfers from neurons to oligodendrocytes. Glia. 2014;62:387\u201398.","journal-title":"Glia"},{"key":"279_CR103","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","volume":"110","author":"JC Watts","year":"2013","unstructured":"Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, et al. Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci. 2013;110:19555\u201360.","journal-title":"Proc Natl Acad Sci"},{"key":"279_CR104","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","volume":"112","author":"SB Prusiner","year":"2015","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, et al. Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci U S A. 2015;112:E5308\u20135317. doi: 10.1073\/pnas.1514475112 .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"279_CR105","doi-asserted-by":"crossref","first-page":"e39465","DOI":"10.1371\/journal.pone.0039465","volume":"7","author":"E Angot","year":"2012","unstructured":"Angot E, Steiner JA, Tom\u00e9 CML, Ekstr\u00f6m P, Mattsson B, Bj\u00f6rklund A, et al. Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo. PLoS One. 2012;7:e39465.","journal-title":"PLoS One"},{"key":"279_CR106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/WNR.0b013e3283509842","volume":"23","author":"E Rockenstein","year":"2012","unstructured":"Rockenstein E, Ubhi K, Inglis C, Mante M, Patrick C, Adame A, et al. Neuronal to oligodendroglial alpha-synuclein redistribution in a double transgenic model of multiple system atrophy. Neuroreport. 2012;23:259.","journal-title":"Neuroreport"},{"key":"279_CR107","first-page":"145","volume":"55","author":"H Jin","year":"2008","unstructured":"Jin H, Ishikawa K, Tsunemi T, Ishiguro T, Amino T, Mizusawa H. Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy. J Med Dent Sci. 2008;55:145\u201353.","journal-title":"J Med Dent Sci"},{"key":"279_CR108","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00702-005-0378-1","volume":"112","author":"D Miller","year":"2005","unstructured":"Miller D, Johnson J, Solano S, Hollingsworth Z, Standaert D, Young A. Absence of \u03b1-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm. 2005;112:1613\u201324.","journal-title":"J Neural Transm"},{"key":"279_CR109","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s004010100367","volume":"102","author":"T Ozawa","year":"2001","unstructured":"Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, Tsuji S. Analysis of the expression level of alpha-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. 2001;102:188\u201390.","journal-title":"Acta Neuropathol"},{"key":"279_CR110","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.21671","volume":"22","author":"N Stefanova","year":"2007","unstructured":"Stefanova N, Reindl M, Neumann M, Kahle PJ, Poewe W, Wenning GK. Microglial activation mediates neurodegeneration related to oligodendroglial \u03b1\u2010synucleinopathy: Implications for multiple system atrophy. Mov Disord. 2007;22:2196\u2013203.","journal-title":"Mov Disord"},{"key":"279_CR111","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-011-9294-3","volume":"21","author":"N Stefanova","year":"2012","unstructured":"Stefanova N, Georgievska B, Eriksson H, Poewe W, Wenning GK. Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. Neurotox Res. 2012;21:393\u2013404.","journal-title":"Neurotox Res"},{"key":"279_CR112","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jnr.20233","volume":"78","author":"N Stefanova","year":"2004","unstructured":"Stefanova N, Mitschnigg M, Ghorayeb I, Diguet E, Geser F, Tison F, et al. Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration. J Neurosci Res. 2004;78:87\u201391.","journal-title":"J Neurosci Res"},{"key":"279_CR113","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1001\/archneur.59.12.1937","volume":"59","author":"Group PS","year":"2002","unstructured":"Group PS. A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study. Arch Neurol. 2002;59:1937.","journal-title":"Arch Neurol"},{"key":"279_CR114","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(05)71083-7","volume":"365","author":"O Rascol","year":"2005","unstructured":"Rascol O, Brooks D, Melamed E, Oertel W, Poewe W, Stocchi F, et al. Rasagiline as an adjunct to levodopa in patients with Parkinson\u2019s disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet. 2005;365:947\u201354.","journal-title":"Lancet"},{"key":"279_CR115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","volume":"361","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, et al. A double-blind, delayed-start trial of rasagiline in Parkinson\u2019s disease. N Engl J Med. 2009;361:1268\u201378.","journal-title":"N Engl J Med"},{"key":"279_CR116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuint.2003.08.005","volume":"44","author":"W Maruyama","year":"2004","unstructured":"Maruyama W, Nitta A, Shamoto-Nagai M, Hirata Y, Akao Y, Yodim M, et al. N\u2009\u2212\u2009Propargyl-1 (R)-aminoindan, rasagiline, increases glial cell line-derived neurotrophic factor (GDNF) in neuroblastoma SH-SY5Y cells through activation of NF-\u03baB transcription factor. Neurochem Int. 2004;44:393\u2013400.","journal-title":"Neurochem Int"},{"key":"279_CR117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1403.011","volume":"1122","author":"O Weinreb","year":"2007","unstructured":"Weinreb O, Amit T, BAR AM O, Youdim MB. Induction of Neurotrophic Factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil. Ann N Y Acad Sci. 2007;1122:155\u201368.","journal-title":"Ann N Y Acad Sci"},{"key":"279_CR118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.expneurol.2007.11.022","volume":"210","author":"N Stefanova","year":"2008","unstructured":"Stefanova N, Poewe W, Wenning GK. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol. 2008;210:421\u20137.","journal-title":"Exp Neurol"},{"key":"279_CR119","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3727\/096368910X540630","volume":"20","author":"H-J Park","year":"2011","unstructured":"Park H-J, Bang G, Lee BR, Kim HO, Lee PH. Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. Cell Transplant. 2011;20:827\u201335.","journal-title":"Cell Transplant"},{"key":"279_CR120","doi-asserted-by":"crossref","first-page":"e19808","DOI":"10.1371\/journal.pone.0019808","volume":"6","author":"S Stemberger","year":"2011","unstructured":"Stemberger S, Jamnig A, Stefanova N, Lepperdinger G, Reindl M, Wenning GK. Mesenchymal stem cells in a transgenic mouse model of multiple system atrophy: immunomodulation and neuroprotection. PLoS One [Electronic Resource]. 2011;6:e19808.","journal-title":"PLoS One [Electronic Resource]"},{"key":"279_CR121","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.clpt.6100454","volume":"83","author":"N Quinn","year":"2008","unstructured":"Quinn N, Barker RA, Wenning GK. Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective? Clin Pharmacol Ther. 2008;83:663\u20135.","journal-title":"Clin Pharmacol Ther"},{"key":"279_CR122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0039.2006.00739.x","volume":"69","author":"J Stagg","year":"2007","unstructured":"Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens. 2007;69:1\u20139.","journal-title":"Tissue Antigens"},{"key":"279_CR123","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1124\/jpet.107.119628","volume":"322","author":"L Cherian","year":"2007","unstructured":"Cherian L, Goodman JC, Robertson C. Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J Pharmacol Exp Ther. 2007;322:789\u201394. doi: 10.1124\/jpet.107.119628 .","journal-title":"J Pharmacol Exp Ther"},{"key":"279_CR124","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1161\/STROKEAHA.107.483008","volume":"38","author":"M Iwai","year":"2007","unstructured":"Iwai M, Cao G, Yin W, Stetler RA, Liu J, Chen J. Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia\/ischemia in rats. Stroke. 2007;38:2795\u2013803. doi: 10.1161\/STROKEAHA.107.483008 .","journal-title":"Stroke"},{"key":"279_CR125","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1523\/JNEUROSCI.20-19-07377.2000","volume":"20","author":"L Studer","year":"2000","unstructured":"Studer L, Csete M, Lee S-H, Kabbani N, Walikonis J, Wold B, et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci. 2000;20:7377\u201383.","journal-title":"J Neurosci"},{"key":"279_CR126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3940(02)00041-1","volume":"321","author":"S Genc","year":"2002","unstructured":"Genc S, Akhisaroglu M, Kuralay F, Genc K. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett. 2002;321:73\u20136.","journal-title":"Neurosci Lett"},{"key":"279_CR127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2005.10.078","volume":"1068","author":"NM Kanaan","year":"2006","unstructured":"Kanaan NM, Collier TJ, Marchionini DM, McGuire SO, Fleming MF, Sortwell CE. Exogenous erythropoietin provides neuroprotection of grafted dopamine neurons in a rodent model of Parkinson\u2019s disease. Brain Res. 2006;1068:221\u20139.","journal-title":"Brain Res"},{"key":"279_CR128","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.23474","volume":"26","author":"M Kollensperger","year":"2011","unstructured":"Kollensperger M, Krismer F, Pallua A, Stefanova N, Poewe W, Wenning GK. Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy. Mov Disord. 2011;26:507\u201315.","journal-title":"Mov Disord"},{"key":"279_CR129","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/WNR.0b013e32830b3661","volume":"19","author":"K Ubhi","year":"2008","unstructured":"Ubhi K, Rockenstein E, Mante M, Patrick C, Adame A, Thukral M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy. Neuroreport. 2008;19:1271\u20136. doi: 10.1097\/WNR.0b013e32830b3661 .","journal-title":"Neuroreport"},{"key":"279_CR130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(13)70301-6","volume":"13","author":"PA Low","year":"2014","unstructured":"Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, et al. Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:268\u201375.","journal-title":"Lancet Neurol"},{"key":"279_CR131","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1097\/00001756-200207190-00018","volume":"13","author":"JG Culvenor","year":"2002","unstructured":"Culvenor JG, Rietze RL, Bartlett PF, Masters CL, Li QX. Oligodendrocytes from neural stem cells express alpha-synuclein: increased numbers from presenilin 1 deficient mice. Neuroreport. 2002;13:1305\u20138.","journal-title":"Neuroreport"},{"key":"279_CR132","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/exnr.2002.7929","volume":"176","author":"F Mori","year":"2002","unstructured":"Mori F, Tanji K, Yoshimoto M, Takahashi H, Wakabayashi K. Demonstration of alpha-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment. Exp Neurol. 2002;176:98\u2013104.","journal-title":"Exp Neurol"},{"key":"279_CR133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U","volume":"62","author":"C Richter-Landsberg","year":"2000","unstructured":"Richter-Landsberg C, Gorath M, Trojanowski JQ, Lee VMY. \u03b1\u2010synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J Neurosci Res. 2000;62:9\u201314.","journal-title":"J Neurosci Res"},{"key":"279_CR134","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1212\/01.wnl.0000271080.53272.c7","volume":"70","author":"T-B Ahn","year":"2008","unstructured":"Ahn T-B, Kim S, Kim J, Park S-S, Lee D, Min H, et al. \u03b1-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology. 2008;70:43\u20139.","journal-title":"Neurology"},{"key":"279_CR135","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","volume":"364","author":"M-C Chartier-Harlin","year":"2004","unstructured":"Chartier-Harlin M-C, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. \u03b1-Synuclein locus duplication as a cause of familial Parkinson\u2019s disease. Lancet. 2004;364:1167\u20139.","journal-title":"Lancet"},{"key":"279_CR136","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"A Singleton","year":"2003","unstructured":"Singleton A, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, et al. \u03b1-Synuclein locus triplication causes Parkinson\u2019s disease. Science. 2003;302:841.","journal-title":"Science"},{"key":"279_CR137","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","volume":"134","author":"I-H Park","year":"2008","unstructured":"Park I-H, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134:877\u201386.","journal-title":"Cell"},{"key":"279_CR138","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"279_CR139","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature07677","volume":"457","author":"AD Ebert","year":"2008","unstructured":"Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008;457:277\u201380.","journal-title":"Nature"},{"key":"279_CR140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","volume":"480","author":"P Koch","year":"2011","unstructured":"Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, et al. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease. Nature. 2011;480:543\u20136.","journal-title":"Nature"},{"key":"279_CR141","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.1245296","volume":"342","author":"CY Chung","year":"2013","unstructured":"Chung CY, Khurana V, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science. 2013;342:983\u20137. doi: 10.1126\/science.1245296 .","journal-title":"Science"},{"key":"279_CR142","doi-asserted-by":"crossref","first-page":"15921","DOI":"10.1073\/pnas.1010209107","volume":"107","author":"G Hargus","year":"2010","unstructured":"Hargus G, Cooper O, Deleidi M, Levy A, Lee K, Marlow E, et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci. 2010;107:15921\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"279_CR143","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.cell.2009.02.013","volume":"136","author":"F Soldner","year":"2009","unstructured":"Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, et al. Parkinson\u2019s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136:964\u201377.","journal-title":"Cell"},{"key":"279_CR144","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul M, Holmqvist S, Boza-Serrano A, Azevedo C, Yeung MS, Goldwurm S, et al. Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human Models. Stem cell reports. 2015;5:174\u201384. doi: 10.1016\/j.stemcr.2015.07.002 .","journal-title":"Stem cell reports"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-016-0279-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T07:54:51Z","timestamp":1718351691000},"score":1,"resource":{"primary":{"URL":"http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-016-0279-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":144,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["279"],"URL":"https:\/\/doi.org\/10.1186\/s40478-016-0279-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]},"article-number":"12"}}